Closing Bell Recap: Neurocrine Biosciences, Inc. (NBIX) Ends at 116.49, Reflecting a -1.07 Downturn

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) closed the day trading at $116.49 down -1.07% from the previous closing price of $117.75. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 0.88 million shares were traded. NBIX stock price reached its highest trading level at $117.89 during the session, while it also had its lowest trading level at $116.05.

Ratios:

For a better understanding of NBIX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.78. For the most recent quarter (mrq), Quick Ratio is recorded 4.08 and its Current Ratio is at 4.19. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 29, 2024, Upgraded its rating to Overweight and sets its target price to $159 from $131 previously.

On April 24, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $140 to $170.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 13 ’24 when Boyer David W. sold 3,461 shares for $121.88 per share. The transaction valued at 421,828 led to the insider holds 1,672 shares of the business.

DAVID WARREN BOYER bought 4,756 shares of NBIX for $576,808 on Sep 13 ’24. On Aug 15 ’24, another insider, RASTETTER WILLIAM H, who serves as the Director of the company, sold 14,250 shares for $146.69 each. As a result, the insider received 2,090,332 and left with 37,491 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NBIX now has a Market Capitalization of 11762694144 and an Enterprise Value of 11015422976. As of this moment, Neurocrine’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.19, and their Forward P/E ratio for the next fiscal year is 16.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.55 while its Price-to-Book (P/B) ratio in mrq is 4.68. Its current Enterprise Value per Revenue stands at 5.197 whereas that against EBITDA is 19.346.

Stock Price History:

Over the past 52 weeks, NBIX has reached a high of $157.98, while it has fallen to a 52-week low of $103.63. The 50-Day Moving Average of the stock is -15.77%, while the 200-Day Moving Average is calculated to be -14.56%.

Shares Statistics:

Over the past 3-months, NBIX traded about 908.01K shares per day on average, while over the past 10 days, NBIX traded about 893340 shares per day. A total of 100.98M shares are outstanding, with a floating share count of 98.78M. Insiders hold about 2.17% of the company’s shares, while institutions hold 93.04% stake in the company. Shares short for NBIX as of 1724976000 were 2135372 with a Short Ratio of 2.35, compared to 1722384000 on 2671781. Therefore, it implies a Short% of Shares Outstanding of 2135372 and a Short% of Float of 2.48.

Most Popular